A bstract Background: Thyroid disorders are frequently encountered among women of reproductive age and are associated with adverse outcomes for both maternal well-being and fetal development. In Bangladesh, thyroid dysfunction continues to be common despite the overall iodine sufficiency. A nationwide survey of physicians revealed notable inconsistencies between international guideline recommendations and routine local clinical practice, underscoring the need for updated, context-specific, and evidence-based guidance. Materials and Methods: The Thyroid Task Force of the Bangladesh Endocrine Society (BES) formulated these updated recommendations by synthesizing international best practices—particularly those from the American Thyroid Association and the Endocrine Society—with locally generated evidence. The committee systematically reviewed the 2023 guidelines to identify areas requiring modification in light of the emerging clinical data and prevailing practice patterns in Bangladesh. Results: The 2026 BES updates offer detailed recommendations on universal screening strategies, trimester-specific interpretation of thyroid function tests, and the management of hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid-related emergencies. Emphasis has been placed on pragmatic, resource-sensitive approaches aligned with the national healthcare infrastructure, with additional focus on postpartum thyroid care. Conclusion: The BES 2026 guidelines establish a unified and practical framework for improving the diagnosis and management of thyroid disorders in Bangladesh. By aligning global evidence with local healthcare realities, these recommendations aim to minimize preventable maternal and neonatal morbidity across diverse clinical settings.
Selim et al. (Mon,) studied this question.